Literature DB >> 16322374

Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.

Tetsutaro Nagaoka1, Sarah A Gebb, Vijaya Karoor, Noriyuki Homma, Kenneth G Morris, Ivan F McMurtry, Masahiko Oka.   

Abstract

The fawn-hooded rat (FHR) develops severe pulmonary hypertension (PH) when raised for the first 3-4 wk of life in the mild hypoxia of Denver's altitude (5,280 ft.). The PH is associated with sustained pulmonary vasoconstriction and pulmonary artery remodeling. Furthermore, lung alveolarization and vascularization are reduced in the Denver FHR. We have recently shown that RhoA/Rho kinase signaling is involved in both vasoconstriction and vascular remodeling in animal models of hypoxic PH. In this study, we investigated the role of RhoA/Rho kinase signaling in the PH of Denver FHR. In alpha-toxin permeabilized pulmonary arteries from Denver FHR, the contractile sensitivity to Ca2+ was increased compared with those from sea-level FHR. RhoA activity and Rho kinase I protein expression in pulmonary arteries of Denver FHR (10-wk-old) were higher than in those of sea-level FHR. Acute inhalation of the Rho kinase inhibitor fasudil selectively reduced the elevated pulmonary arterial pressure in Denver FHR in vivo. Chronic fasudil treatment (30 mg.kg-1.day-1, from birth to 10 wk old) markedly reduced the development of PH and improved lung alveolarization and vascularization in Denver FHR. These results suggest that Rho kinase-mediated sustained vasoconstriction, through increased Ca2+ sensitivity, plays an important role in the established PH and that RhoA/Rho kinase signaling contributes significantly to the development of PH and lung dysplasia in mild hypoxia-exposed FHR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322374     DOI: 10.1152/japplphysiol.01028.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  34 in total

1.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

Review 2.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

Authors:  M Oka; K A Fagan; P L Jones; I F McMurtry
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

3.  Long-term maternal hypoxia: the role of extracellular Ca2+ entry during serotonin-mediated contractility in fetal ovine pulmonary arteries.

Authors:  Ravi Goyal; Demosthenes G Papamatheakis; Matthew Loftin; Kurt Vrancken; Antoinette S Dawson; Noah J Osman; Arlin B Blood; William J Pearce; Lawrence D Longo; Sean M Wilson
Journal:  Reprod Sci       Date:  2011-10       Impact factor: 3.060

4.  Mitogen-activated protein kinase phosphatase-1 is a key regulator of hypoxia-induced vascular endothelial growth factor expression and vessel density in lung.

Authors:  Kristin M Shields; Evgeniy Panzhinskiy; Nana Burns; W Michael Zawada; Mita Das
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 5.  Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem.

Authors:  Jeremy P T Ward; Ivan F McMurtry
Journal:  Curr Opin Pharmacol       Date:  2009-03-16       Impact factor: 5.547

6.  Fasudil inhibits the myogenic response in the fetal pulmonary circulation.

Authors:  Pierre Tourneux; Marc Chester; Theresa Grover; Steven H Abman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-01       Impact factor: 4.733

7.  Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.

Authors:  K M Mair; M R MacLean; I Morecroft; Y Dempsie; T M Palmer
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

8.  Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro.

Authors:  Jason Gien; Gregory J Seedorf; Vivek Balasubramaniam; Nancy Tseng; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

9.  Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.

Authors:  Cassidy Delaney; Jason Gien; Gates Roe; Nicole Isenberg; Jenai Kailey; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-19       Impact factor: 5.464

Review 10.  Pulmonary hypertension: therapeutic targets within the serotonin system.

Authors:  Y Dempsie; M R MacLean
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.